Latest News Canada to create national drug agency to help cut cost of medicines Bermuda Health Council Accepted Into RedETSA Health Canada & HTA Body CADTH To Offer Parallel Scientific Advice UHC Act: The role of Health Technology Novartis first to benefit from NICE advice on ‘patient preference’ NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice International HTA Agencies Collaborate On How To Determine Value-Based Prices Japan shares its universal health coverage knowledge with Egypt Leading Global Experts Identify Good Practices in the Use of Evidence to Inform Decision Making for Health Technologies Harmonizing HTA Methodological Standards Across EU Member States: Benefits and Challenges ISPOR HTA Council Chair presents at the 1st China HTA Conference New EU law to inform medicine pricing Health technology assessments receive European Parliament backing European Parliament further clarifies Commission proposal on HTA for medical technologies New Law to Boost EU-level Cooperation on Health Tech Assessments Ghana receives accolades for progress in universal health coverage EUnetHTA Magazine – Summer 2018 Step therapy will drive drug-price concessions, AHIP says Professor says HSE should ‘take seriously’ cheaper medicines CVS sets a cost-effectiveness threshold for health plan coverage of most new drugs Upcoming Events ISPOR Warsaw 2019 March 27 - 28, 2019 Warsaw, Poland CADTH Symposium April 14 - 16, 2019 Edmonton, Alberta Canada Save the Date: HEOR Short Courses (at ISPOR 2019) May 18 - 19, 2019 New Orleans, LA United States ISPOR 2019 May 18 - 22, 2019 New Orleans, LA United States 2019 INAHTA Congress (at HTAi 2019 Cologne) June 19 - 20, 2019 Cologne, Germany
NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice
Leading Global Experts Identify Good Practices in the Use of Evidence to Inform Decision Making for Health Technologies
